Metabolic reprogramming involves in transition of activated/resting CD4+ memory T cells and prognosis of gastric cancer

Abstract

Our study showed that metabolic reprogramming including retinoic acid metabolism could contribute to transition of activated and resting CD4⁺ memory T cells, and affect prognosis of GC patients. The ARMG risk model could serve as a new tool for GC patients by accurately predicting prognosis and response to treatment.